| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ciliobrevin D | 1370554-01-0 | sc-507482 | 10 mg | $413.00 | ||
Ciliobrevin D is an inhibitor of dynein, indirectly modulating DYNLL1 by disrupting the dynein-mediated transport processes in the cell, affecting DYNLL1 localization and function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, affecting endocytosis. Since DYNLL1 is involved in endocytic processes, Dynasore indirectly influences DYNLL1 function by disrupting endocytosis and related cellular processes. | ||||||
CC-401 | 395104-30-0 | sc-364748 sc-364748A | 2 mg 10 mg | $331.00 $1060.00 | 4 | |
CC-401, a receptor tyrosine kinase (RTK) inhibitor, can indirectly modulate DYNLL1 by affecting signaling pathways associated with RTKs that regulate DYNLL1 function. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Ro 31-8220 is a pan-PKC (protein kinase C) inhibitor that can indirectly modulate DYNLL1 by affecting PKC-mediated signaling pathways associated with DYNLL1 regulation. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML7 is a myosin light chain kinase (MLCK) inhibitor that can indirectly modulate DYNLL1 by affecting the actin cytoskeleton and related cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK, indirectly influencing DYNLL1 by disrupting the p38 MAPK signaling pathway associated with DYNLL1 regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can indirectly modulate DYNLL1 by affecting the PI3K/Akt signaling pathway, which is implicated in DYNLL1-related cellular processes. | ||||||
Tyrphostin AG 879 | 148741-30-4 | sc-3557 sc-3557A | 5 mg 25 mg | $83.00 $328.00 | 4 | |
AG-879 is a tyrosine kinase inhibitor, indirectly modulating DYNLL1 by affecting signaling pathways related to tyrosine kinases involved in DYNLL1 regulation. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine is an inhibitor of autophagy, impacting DYNLL1 by influencing the autophagic processes in which DYNLL1 is involved. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective JNK (c-Jun N-terminal kinase) inhibitor that can indirectly modulate DYNLL1 by disrupting the JNK signaling pathway associated with DYNLL1 regulation. | ||||||